Skip to main content

Home News / Articles ListDetails

News / Articles

FDA approves first generic naloxone nasal spray to treat opioid overdose

Published on 4/23/2019

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm

Return to Previous Page

PO Box 88443
Sioux Falls, SD 57109

Promoting Health.
Preventing Disease.
Protecting South Dakotans.